Phenotypic and genotypic spectrum of Turkish patients with isovaleric acidemia

Eur J Med Genet. 2014 Oct;57(10):596-601. doi: 10.1016/j.ejmg.2014.08.006. Epub 2014 Sep 8.

Abstract

We aim to investigate the genetic basis of isovaleryl-CoA dehydrogenase (IVD) gene mutations and genotype-phenotype correlations in Turkish patients. Accordingly, bi-directional sequencing was performed to screen 26 patients with isovaleric acidemia (IVA). Nine novels (c.145delC, c.234 + 3G > C, c.506_507insT, p.Glu85Gln, p.Met147Val, p.Ala268Val, p.Ile287Met, p.Gly346Asp and p.Arg382Trp) and six previously reported (c.456 + 2T > C, p.Arg21His, p.Arg21Pro, p.Arg363Cys, p.Arg363His p.Glu379Lys) pathogenic mutations were identified. Pathogenicity of the novel mutations was supported using computational programs. No clear genotype-phenotype correlation could be determined. One of the cases with the novel c.234 + 3G > C mutation has portoseptal liver fibrosis, the clinical condition that was first reported for IVA. This study is the first comprehensive report from Turkey related to IVA genetics that provides information about the high number of disease-causing novel mutations.

Keywords: Genotype–phenotype correlation; IVD gene; Isovaleric acidemia; Mutation screening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Amino Acid Metabolism, Inborn Errors / genetics*
  • Child
  • Child, Preschool
  • Consanguinity
  • Female
  • Genetic Heterogeneity
  • Genotype
  • Humans
  • Infant
  • Isovaleryl-CoA Dehydrogenase / deficiency*
  • Isovaleryl-CoA Dehydrogenase / genetics
  • Male
  • Mutation
  • Phenotype
  • RNA Splicing
  • Turkey
  • Young Adult

Substances

  • Isovaleryl-CoA Dehydrogenase

Supplementary concepts

  • Acidemia, isovaleric